Close Menu

NEW YORK ─ The US Food and Drug Administration in November granted a few 510(k) clearances for in vitro diagnostic companies, according to the agency's website.

The diagnostics division of Basel, Switzerland-based Roche got the green light for its Cobas u 701 analyzer, a fully automated stand-alone urine analysis system optimized for high-volume laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.